Search - tctmd.com

Displaying 1 - 20 of 119

Sort: Relevancy | Date

News Daily News

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Michael O'Riordan

December 30, 2022

News Daily News

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Caitlin E. Cox

December 30, 2022

News Daily News

Top General Cardiology and Prevention News of 2022

Michael O'Riordan

December 26, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

Michael O'Riordan

December 13, 2022

News Daily News

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

L.A. McKeown

December 06, 2022

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Daily News

Impella RP Mortality Rate No Longer a Concern, FDA Says

Caitlin E. Cox

December 05, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News AHA 2022

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

Michael O'Riordan

November 06, 2022

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

News Daily News

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

Caitlin E. Cox

October 20, 2022

News Daily News

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

Michael O'Riordan

October 17, 2022

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Todd Neale

October 12, 2022

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

Advertisement

Semaglutide Effective for Weight Loss in Adolescents: STEP TEENS

Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study

Top General Cardiology and Prevention News of 2022

Reduction in BP Drives Treatment Preference for Hypertensive Patients

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Big Tobacco Scores a Win Against Graphic Warning Labels on Cigarette Packs

FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

Impella RP Mortality Rate No Longer a Concern, FDA Says

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

Common ‘Heart’ Supplements Can’t Beat Statins: SPORT

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

November 2022 News Roundup

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

US Claims Data Point to Better Survival With Impella vs IABP in High-Risk PCI

FDA: New Fix Available for Medtronic’s Troubled HeartWare VADs

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content